Table 2. Comparison of perioperative parameters between with/without thrombocytosis group.
| Characteristic | Without thrombocytosis (n=167) | With thrombocytosis (n=20) | p-value |
|---|---|---|---|
| Age (y) | 0.992 | ||
| <60 | 100 (89.3) | 12 (10.7) | |
| ≥60 | 67 (89.3) | 8 (14.7) | |
| Sex | 0.069 | ||
| Male | 126 (92.6) | 10 (7.4) | |
| Female | 41 (80.4) | 10 (19.6) | |
| Histology | 0.215 | ||
| Clear cell | 143 (90.5) | 15 (9.5) | |
| Nonclear cell | 24 (82.8) | 5 (17.2) | |
| T stage | 0.028 | ||
| T1+T2 | 153 (91.6) | 14 (8.4) | |
| T3+T4 | 14 (70.0) | 6 (30.0) | |
| Grade | 0.122 | ||
| G1+G2 | 88 (92.7) | 7 (7.3) | |
| G3+G4 | 79 (85.7) | 13 (14.3) | |
| Tumor size (cm) | 0.446 | ||
| <7 | 137 (90.1) | 15 (9.9) | |
| ≥7 | 30 (85.7) | 5 (14.3) | |
| Distant metastasis | 0.001 | ||
| No | 147 (93.6) | 10 (6.4) | |
| Yes | 20 (66.7) | 10 (33.3) | |
| NLR | 0.003 | ||
| <1.81 | 83 (96.5) | 3 (3.5) | |
| ≥1.81 | 84 (83.2) | 17 (16.8) | |
| PLR | 0.001 | ||
| <128.7 | 84 (98.8) | 1 (1.2) | |
| ≥128.7 | 83 (81.4) | 19 (18.6) | |
| Cancer death | 0.001 | ||
| No | 161 (90.4) | 17 (9.6) | |
| Yes | 6 (67.0) | 3 (33.0) |
Values are presented as number (%).
NLR, neutrophil to lymphocyte ratio; PLR, platelet to lymphocyte ratio.